Literature DB >> 17761997

Screening for diabetes.

Ronald P Stolk.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17761997      PMCID: PMC1971182          DOI: 10.1136/bmj.39323.395336.BE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria.

Authors:  N J Wareham; S J Griffin
Journal:  BMJ       Date:  2001-04-21

Review 2.  Screening for type 2 diabetes.

Authors:  M M Engelgau; K M Narayan; W H Herman
Journal:  Diabetes Care       Date:  2000-10       Impact factor: 19.112

3.  Psychological outcomes of patients with screen-detected type 2 diabetes: the influence of time since diagnosis and treatment intensity.

Authors:  Bart J Thoolen; Denise T de Ridder; Jozien M Bensing; Kees J Gorter; Guy E Rutten
Journal:  Diabetes Care       Date:  2006-10       Impact factor: 19.112

4.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

Authors:  M Coutinho; H C Gerstein; Y Wang; S Yusuf
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

5.  The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening.

Authors:  T Lauritzen; S Griffin; K Borch-Johnsen; N J Wareham; B H Wolffenbuttel; G Rutten
Journal:  Int J Obes Relat Metab Disord       Date:  2000-09

Review 6.  Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Stacey Sheridan; Michael Pignone; Katrina Donahue
Journal:  Am J Prev Med       Date:  2003-08       Impact factor: 5.043

7.  Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.

Authors:  Paul G H Janssen; Kees J Gorter; Ronald P Stolk; Guy E H M Rutten
Journal:  Prim Care Diabetes       Date:  2007-03-29       Impact factor: 2.459

8.  What determines the cost-effectiveness of diabetes screening?

Authors:  C Glümer; M Yuyun; S Griffin; D Farewell; D Spiegelhalter; A L Kinmonth; N J Wareham
Journal:  Diabetologia       Date:  2006-04-26       Impact factor: 10.122

9.  Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial.

Authors:  Helen C Eborall; Simon J Griffin; A Toby Prevost; Ann-Louise Kinmonth; David P French; Stephen Sutton
Journal:  BMJ       Date:  2007-08-30

10.  Patients' experiences of screening for type 2 diabetes: prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial.

Authors:  Helen Eborall; Richard Davies; Ann-Louise Kinmonth; Simon Griffin; Julia Lawton
Journal:  BMJ       Date:  2007-08-30
  10 in total
  1 in total

1.  Ten-Year Trends in the Morbidity of Diabetes Mellitus and Antidiabetic Drug Utilization in Croatia: A Study Based on Routinely Collected Data.

Authors:  Renata Pavlov; Ivančica Topličan; Mladenka Vrcić Keglević
Journal:  Int J Family Med       Date:  2016-07-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.